Summary
Mr. Yongxian Li is a dedicated researcher specializing in the prevention and treatment of osteoporosis using Traditional Chinese Medicine (TCM). His work focuses on regulating bone metabolism by modulating key pathways like MAPK and PI3K/AKT, offering innovative approaches to improve bone health and reduce fracture risks.
Education
Graduated from Guangzhou University of Chinese Medicine, with a focus on osteology and TCM therapies.
Professional Experience
Mr. Yongxian Li is affiliated with The First Affiliated Hospital of Guangzhou University of Chinese Medicine. He has led impactful projects, including studies on Buqi-Tongluo Decoction and its effects on osteoclastogenesis and bone loss, contributing significantly to osteoporosis research.
Research Interests
His primary interest lies in utilizing Traditional Chinese Medicine to enhance bone health. He explores the effects of TCM monomers on osteoblast and osteoclast activity, focusing on signaling pathways to restore bone metabolic balance effectively.
Publications